Adenoid cystic carcinoma (AdCC) is among the most common malignant tumors of the salivary glands. It is characterized by a prolonged clinical course, with frequent local recurrences, late onset of metastases and fatal outcome. High-grade transformation (HGT) is an uncommon phenomenon among salivary carcinomas and is associated with increased tumor aggressiveness. In AdCC with high-grade transformation (AdCC-HGT), the clinical course deviates from the natural history of AdCC. It tends to be accelerated, with a high propensity for lymph node metastasis. In order to shed light on this rare event and, in particular, on treatment implications, we undertook this review: searching for all published cases of AdCC-HGT. We conclude
that it is mandatory to perform elective neck dissection in patients with AdCC-HGT, due to the high risk of lymph node metastases associated with transformation. 
REVIEW
The concept of high-grade transformation (previously also termed dedifferentiation) in neoplasms was introduced in 1971. Dahlin and Beabout [1] described a distinct entity in which a low grade chondrosarcoma was associated with a histologically high-grade sarcoma. High-grade transformation (HGT) in salivary gland tumors is rare but has been described not only in adenoid cystic carcinoma (AdCC) but in acinic cell carcinoma (AcCC) [2] [3] [4] [5] [6] [7] , polymorphous low-grade adenocarcinoma [8-10], epithelial-myoepithelial carcinoma [11] [12] [13] [14] , low-grade mucoepidermoid carcinoma [15] , myoepithelial carcinoma [16] , hyalinizing clear cell carcinoma [17, 18] , and mammary analogue secretory carcinoma (MASC) [19, 20] . The molecular genetic mechanisms responsible for these transformations remain largely unknown but a few genes have been documented in HGT of salivary gland neoplasms, such as P53 gene mutation and C-MYC amplification [21] [22] [23] [24] . HGT in salivary tumors of low-grade malignancy, such as AcCC, is associated with a higher local recurrence rate, a higher propensity for local lymph node metastasis and, a dramatic worsening of prognosis. For example, AcCC has the best prognosis of all salivary malignancies (10-year survival *90%), but HGT in AcCC significantly reduces the mean survival of patients to 4.3 years [5, 25] .
HGT in AdCC (AdCC-HGT) was first described in 1999 by Cheuk et al. [26] as ''dedifferentiated adenoid cystic carcinoma'' and since then more than 40 cases have been reported in the literature, most of them involving sinonasal and palatal minor glands and the submandibular glands [21, 23, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . There are statements that AdCC-HGT has a high propensity for lymph node metastasis, with as many as 57% of the patients showing metastatic disease compared to 5-25% of patients with conventional AdCC (cribriform, tubular and solid patterns) [33, 46] . The risk for nodal disease in AdCC-HGT is likely to be The subtype of AdCC among the seven patients who developed nodal disease was not specifically stated [44] .
AdCC
The concept of HGT in AdCC was widely accepted after the publication of Cheuk et al. [47] and another one in 2014 [45] comprised 8 cases; 7 of the cases derived from the 2010 study by Bonfitto et al. [23] and the additional 8th case from the 2011 study by Costa et al. [36] . In the 2014 study by Costa et al. [45] , it is stated that this same particular palatal tumor did not have any cervical lymph node metastasis b In the 2011 study, Costa et al. [36] reported 6 cases of AdCC-HGT, however, 5 of the cases were included in the previous 2010 study by Bonfitto et al. [23] ; hence only one new case presented in this 2011 study by Costa et al. [36] histologic evaluation help to identify any possible focus of HGT, but may also highlight areas of solid subtype in a conventional AdCC.
CONCLUSION
Based on the literature review, lymph node metastasis may occur in 43-57% of patients with AdCC-HGT. This high propensity for lymph node metastases, which is at least 5-10 times higher than for conventional AdCC, strongly supports the use of neck dissection for patients with this unique histology. Preoperative staging workup is mandatory due to the high risk of distant metastasis.
In situations where such histology is not recognized until after extirpative surgery for the primary, it appears justified to subsequently include the neck electively in the post-operative radiotherapy or perform a postoperative elective neck dissection (if distant metastasis are ruled out) followed by adjuvant radiation therapy to the primary site and the regional lymph nodes. 
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